An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)
Clinical trial NCT05146882 · WITHDRAWN
Trial details
- NCT number
- NCT05146882
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-05-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.